Ziccum AB (publ) (ZICC.ST)
Ziccum AB (publ) operates in the Biotechnology industry of the Healthcare sector, headquartered in Lund, SE. The stock last traded at $0.25, up 0.00% on the session, giving a market capitalisation of $8.6M. Its beta of 1.31 implies it has historically moved more than the broad market.
Ziccum AB (publ) specializes in creating stable dry powder formulations for biological pharmaceuticals. The company's core offering is LaminarPace, a proprietary spray drying technology they develop and commercialize. This innovative system enables the gentle, room-temperature drying of diverse substances, including chemicals, vaccines, biologics, and various other drug compounds. Established in 2017, Ziccum maintains its headquarters in Lund, Sweden.
Ziccum AB (publ) is most often compared with the following Healthcare names: